Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open‐angle glaucoma and ocular hypertension

Latanoprostene bunod (LBN) ophthalmic solution 0.024% is a novel, once‐daily, nitric oxide‐donating prostaglandin analogue for the lowering of intraocular pressure (IOP) in patients with open‐angle glaucoma and ocular hypertension. The IOP‐lowering actions of LBN are mediated by dual mechanisms of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fingeret, Murray, Gaddie, Ian B, Bloomenstein, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899723/
https://www.ncbi.nlm.nih.gov/pubmed/30614563
http://dx.doi.org/10.1111/cxo.12853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899723/
https://www.ncbi.nlm.nih.gov/pubmed/30614563
http://dx.doi.org/10.1111/cxo.12853

Ejemplares similares